Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Emergence Delirium 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Quality of Recovery 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Endobronchial Metastases 1Delirium 1

Interventions

Propofol 4Saline Solution 3Dexmedetomidine 3remimazolam 2Sugammadex 1Sufentanil 1Sodium Chloride 1Ropivacaine 1Pyridostigmine Bromide 1Neuroleptanalgesia 1Nalbuphine 1Minocycline 1Midazolam 1Methylene Blue 1Ketamine 1Injections 1Ibuprofen 1Duloxetine Hydrochloride 1Control Groups 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Emergence Delirium × remimazolam × Clear all
NCT07351474 2026-01-20

Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy

The First Affiliated Hospital with Nanjing Medical University

Phase NA Not yet recruiting
170 enrolled
Gastrointestinal

Emergence Delirium, Stomach Neoplasms

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Peking University First Hospital

Phase 4 Recruiting
1,128 enrolled
Genitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡